Searchable abstracts of presentations at key conferences in endocrinology

ea0037gp.21.05 | Pituitary – Diagnosis of Cushing's disease | ECE2015

Mental fatigue and executive dysfunction in patients with Cushing's syndrome in remission

Papakokkinou Eleni , Berglund Peter , Johansson Birgitta , Ragnarsson Oskar

Background: Patients with Cushing’s syndrome (CS) in remission often suffer from impaired quality of life and cognitive dysfunction. Mental fatigue is characterized by mental exhaustion which appears especially during sensory stimulation or following mentally strenuous tasks. Other typical features are long recovery time for restoration of mental energy, irritability, impaired memory and concentration and sensitivity to stress, light and noise. The primary aim of this stu...

ea0092ps1-02-04 | Graves’ Disease | ETA2023

The relationship between mental fatigue, anxiety and depression in graves disease

Holmberg Mats , Berglund Peter , Johansson Birgitta , Malmgren Helge , Skau Simon , Filipsson Nystrom Helena , Jonsson Annika

Background: Mental fatigue, depression and anxiety are common in Graves’ disease (GD). Our aims were to assess the relationship between these variables among GD patients both in the hyperthyroid phase and after treatment. The pathogenic mechanisms involved in these symptoms are unknown and so is if previous psychiatric disease influences these symptoms.Methods: This was a longitudinal case control study in Göteborg, Sweden, on 65 women with new...

ea0070aep44 | Adrenal and Cardiovascular Endocrinology | ECE2020

Etiology and extent of impaired quality of life, fatigue and affective, cognitive, and emotional dysfunction in patients with cushing’s syndrome – The IQFACE-CS study

de Vries Friso , Papakokkinou Eleni , Santos Alicia , van Haalen Femke , Valassi Elena , Biermasz Nienke , Johansson Birgitta , Gómez-Ansón Beatriz , Bauduin Stéphanie , Resmini Eugenia , van der Wee Nic , Pereira Alberto M , Webb Susan , Ragnarsson Oskar

Background: Patients with Cushing’s Syndrome (CS) suffer from a variety of neuropsychiatric and cognitive problems. Following remission, some, but not all of these symptoms resolve. Recent cross-sectional studies in patients with CS show persistent structural and functional brain abnormalities. However, longitudinal studies using magnetic resonance imaging, and a detailed neurocognitive assessment, performed before and after treatment, are not available.<p class="abs...